26(top 2%)
papers
558(top 2%)
citations
12(top 2%)
h-index
24(top 2%)
g-index
33
all documents
678
doc citations
359
citing journals
40
times ranked

Top Articles

#TitleJournalYearCitations
1COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi studyBMC Medical Research Methodology2020205
2The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritisDrug Delivery and Translational Research201978
3Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical GuideDrugs and Aging201961
4Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*British Journal of Dermatology202152
5Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture preventionExpert Opinion on Pharmacotherapy202047
6Current Treatments and New Developments in the Management of Glucocorticoid-induced OsteoporosisDrugs201937
7An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritisExpert Opinion on Drug Safety201930
8Outcome measures for adherence data from a medication event monitoring system: A literature reviewJournal of Clinical Pharmacy and Therapeutics201927
9An Algorithm for the Diagnosis of Behçet Disease Uveitis in AdultsOcular Immunology and Inflammation202126
10Management of glucocorticoid-induced osteoporosisAging Clinical and Experimental Research202120
11High-intensity versus low-intensity resistance training in patients with knee osteoarthritis: A randomized controlled trialClinical Rehabilitation202216
12Patients’ and rheumatologists’ perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis—an international survey within the GLORIA studyRheumatology202113
13COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseasesLancet Rheumatology, The202212
14Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in EvidencioRheumatology and Therapy202011
15Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid ArthritisFrontiers in Immunology20199
16Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia CellsCells20218
17The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid ArthritisFrontiers in Immunology20217
18In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanomaOncoImmunology20205
19The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidenceCurrent Opinion in Rheumatology20224
20Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working GroupAnnals of the Rheumatic Diseases20203
21The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort studyClinical Rheumatology20222
22Favorable effect of a ‘second hit’ after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trialRheumatology02
23ACPA epitopes — what are we actually looking at?Nature Reviews Rheumatology20191
24Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”Drugs and Aging20201
25Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trialTrials20211
26P70 Increased work loss during pregnancy in women with systemic lupus erythematosus compared to matched healthy controlsTrials20200
27Work participation and sick leave in women with systemic lupus erythematosus and matched controls during and after pregnancyClinical and Experimental Rheumatology20200
28AB0166 PROTOCOL VIOLATIONS IN AN OPEN, RANDOMIZED, TRIAL IN EARLY RA PATIENTS: POTENTIAL IMPACT OF SHARED DECISION MAKINGAnnals of the Rheumatic Diseases20220
29Association Between Measures of Muscle Strength and Performance of Daily Activities in Patients with Knee OsteoarthritisJournal of Rehabilitation Medicine00
30Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoidsRheumatology00